Title:
Novel Therapeutic Methods
Document Type and Number:
WIPO Patent Application WO/2021/180032
Kind Code:
A1
Abstract:
Provided herein are new therapeutic uses for certain fused ring pyrimidine compounds, in particular for treating patients having a cancer which expresses elevated fibroblast growth factor receptor oncogene partner 2 (FGFR1OP2) and/or elevated FGFR1, or expresses a FGFR1-FGFR1OP2 fusion protein, and for treating patients who are being treated with an immune checkpoint inhibitor.
Inventors:
WANG YUGUANG (CN)
FENG ZHENHUA (CN)
WANG FEILAN (CN)
FENG ZHENHUA (CN)
WANG FEILAN (CN)
Application Number:
PCT/CN2021/079532
Publication Date:
September 16, 2021
Filing Date:
March 08, 2021
Export Citation:
Assignee:
GUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD (CN)
International Classes:
A61K31/517; A61K31/519; A61P35/00; C07D239/78; C07D401/14; C07D405/04; C07D405/14; C07D471/04; C07D495/04
Domestic Patent References:
| WO2017012559A1 | 2017-01-26 | |||
| WO2019228171A1 | 2019-12-05 | |||
| WO2016169504A1 | 2016-10-27 | |||
| WO2013150036A1 | 2013-10-10 | |||
| WO2015027222A2 | 2015-02-26 | |||
| WO2007117607A2 | 2007-10-18 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: